Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma.
Lin P, Xie W, Li Y, Zhang C, Wu H, Wan H, Gao M, Liang F, Han P, Chen R, Cheng G, Liu X, Fan S, Huang X.
J Immunother Cancer. 2024 Nov 5;12(11):e009616. doi: 10.1136/jitc-2024-009616.
PMID:39500529
Malignant tumors of the head and neck in young patients.
Naganuma H, Takahashi H, Okamoto M, Yao K, Iwabuchi K.
Pregnancy and malignant neoplasms of the head and neck.
Ferlito A, Devaney SL, Carbone A, Maio M, Devaney KO, Rinaldo A, Friedmann I.
Ann Otol Rhinol Laryngol. 1998 Nov;107(11 Pt 1):991-8. doi: 10.1177/000348949810701116.
PMID:9823852
Clinical manifestation of malignant lymphomas of the head and neck region.
Bojanowska-Poźniak K, Nurkowska M, Danilewicz M, Pietruszewska W.
Otolaryngol Pol. 2017 Dec 30;71(6):14-21. doi: 10.5604/01.3001.0010.7192.
PMID:29327683
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.
Li HS, Tang R, Shi HS, Qin ZJ, Zhang XY, Sun YF, Wei ZG, Ma CF, Yang L, Chen Y, Liu ZR, Zhu LL, Yang W, Yang L, Xu AN, Zhang Z, Liao SQ, Shi JS, Deng JJ, He XZ, Peng XC.
Signal Transduct Target Ther. 2025 Mar 3;10(1):82. doi: 10.1038/s41392-025-02184-0.
PMID:40032871
Research progress and application of single-cell sequencing in head and neck malignant tumors.
Qu S, Gong M, Deng Y, Xiang Y, Ye D.
Cancer Gene Ther. 2024 Jan;31(1):18-27. doi: 10.1038/s41417-023-00691-2. Epub 2023 Nov 15.